Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

News and updates from the PANORAMIC team

PANORAMIC hits the 20,000 participant milestone

General Recruitment

The world’s largest study of community-based treatments for acute COVID-19 has reached a world-first, historic milestone: over twenty thousand participants from across the UK have now taken part in the PANORAMIC trial.

Largest Hindu temple in Europe helps to spread awareness of the PANORAMIC study

General Recruitment

Europe’s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PANORAMIC trial of COVID-19 treatments.

Covid 19: Anti-viral drug study open to patients in NI

General Recruitment Research

New Story from the BBC: People in Northern Ireland are being urged to take part in a study which will help decide how antiviral drugs will be used to treat Covid-19.

University of Bolton student champions praised for support in University of Oxford Covid-19 treatment trials

General New medications Recruitment

Student Champions from the University of Bolton who have helped to recruit volunteers through community outreach work for the world’s largest trials to treat Covid-19 have been congratulated for their hard work.

Over ten thousand participants enrol in world’s largest COVID-19 antiviral study

Over ten thousand participants from right across the UK have now taken part in the NIHR-funded and supported PANORAMIC trial - which is by far the world’s largest study into new antiviral treatments against COVID-19 in community, ambulatory care.

BBC: Patients wanted for Oxford and Southampton Unis' take-at-home pill trial

General Recruitment Research

Researchers studying the use of an antiviral drug people can take at home to treat Covid want thousands more volunteers to join their trial. Scientists at Oxford and Southampton Universities are looking at how molnupiravir can reduce symptoms in people at risk of serious illness. They have signed up 8,000 recently diagnosed with the virus but want thousands more to join the trial.

BBC Inside Health (Radio 4): PANORAMIC and anti-virals featured

General Research

BBC Inside Health speak to Nerys from North Wales who has started antiviral treatment for her COVID-19 infection. They also explore the new drugs with virologist Dr Elisabetta Groppelli and Professor Chris Butler who is running the clinical trial designed to pinpoint who is likely to benefit from antivirals the most. (Skip to 15min in for anti-virals).

The Guardian: How antivirals provide hope to vulnerable COVID-19 patients

General Research

The recent decision by regulators to approve the antiviral agent Paxlovid for use in the UK adds a formidable new weapon to the arsenal of treatments for COVID-19.

New Scientist: UK has begun using drugs for covid-19 cases before they become severe

General Research

Treatments like sotrovimab, molnupiravir and Paxlovid could lead to a new strategy in 2022: tackling COVID-19 soon after infection to prevent severe symptoms from developing

BBC: Hundreds in Wales take antiviral tablets

General Research

A new story from the BBC features people taking part in PANORAMIC from Wales

Recruitment begins for national community COVID-19 antiviral trial

General Recruitment Research

Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.